Christopher Hite
Corporate Officer/Principal chez ROYALTY PHARMA PLC
Fortune : 57 M $ au 30/06/2024
Profil
Christopher Hite's current jobs include Vice Chairman & Executive Vice President at RP Management LLC, Vice Chairman & Executive Vice President at Royalty Pharma Plc, Director at FasterCures, and Trustee at Lehigh University.
His former jobs include Vice Chairman & Global Head-Healthcare at Citigroup, Inc., Independent Director at Acceleron Pharma, Inc., and Global Head-Healthcare Investment Banking at Lehman Brothers Holdings, Inc. He also has experience as Global Head-Healthcare at Community IT Innovators, Inc. Mr. Hite's education includes a graduate degree in MBA from the University of Pittsburgh and an undergraduate degree from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/04/2024 | 1 466 410 ( 0,61% ) | 39 M $ | 30/06/2024 | |
| 13/05/2024 | 370 000 ( 0,08% ) | 10 M $ | 30/06/2024 | |
RPI US Partners 2019 LP
0,15% | 13/05/2024 | 325 000 ( 0,15% ) | 9 M $ | 30/06/2024 |
Postes actifs de Christopher Hite
| Sociétés | Poste | Début |
|---|---|---|
| ROYALTY PHARMA PLC | Corporate Officer/Principal | 01/03/2020 |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/03/2020 |
| FasterCures | Directeur/Membre du Conseil | - |
| Lehigh University | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher Hite
| Sociétés | Poste | Fin |
|---|---|---|
| ACCELERON PHARMA INC. | Directeur/Membre du Conseil | 19/11/2021 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/03/2020 |
Lehman Brothers Holdings, Inc.
 Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Lehman Brothers Holdings, Inc. engages in the provision of securities underwriting and investment services. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2008 |
Community IT Innovators, Inc.
 Community IT Innovators, Inc. Miscellaneous Commercial ServicesCommercial Services Community IT Innovators, Inc. provides business consulting services. The company was founded in 1993 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Formation de Christopher Hite
| Lehigh University | Undergraduate Degree |
| University of Pittsburgh | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ROYALTY PHARMA PLC | Health Technology |
| CITIGROUP INC. | Finance |
| Entreprise privées | 5 |
|---|---|
RP Management LLC
RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Community IT Innovators, Inc.
Community IT Innovators, Inc. Miscellaneous Commercial ServicesCommercial Services Community IT Innovators, Inc. provides business consulting services. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Lehman Brothers Holdings, Inc. engages in the provision of securities underwriting and investment services. The company is headquartered in New York, NY. | Finance |
| FasterCures |
